Jeff J. Ludwig
Chief Commercial Officer
Mr. Ludwig joined Puma Biotechnology as Chief Commercial Officer in March 2020. Mr. Ludwig was Vice
President Oncology Sales for Astellas Pharma Inc., a multinational pharmaceutical company based in
Japan, from 2019 until 2020, where he led multiple sales teams across several oncology therapeutic
products, a significant label expansion in prostate cancer and a new launch in bladder cancer. Prior to
joining Astellas, Mr. Ludwig worked at Amgen Inc., a multinational biopharmaceutical company based in
California, from 2001 until 2019, where he most recently held the position of Vice President Oncology
Sales from 2014 to 2019. During his tenure as Vice President of Oncology Sales, he led the sales
organization through numerous successful launches and contributed to a multi-billion dollar portfolio of
therapeutic and supportive care products. Before assuming the Vice President of Oncology Sales role,
he successfully held various other leadership positions in both oncology sales and marketing. Prior to
joining Amgen, Mr. Ludwig worked in various sales and marketing roles at Eli Lilly and Company from
1988 until 2001.
Mr. Ludwig holds a B.S. in business from Arizona State University, where he graduated with honors.
Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024